Global Drug Delivery Systems Industry Trends and Market Forecast 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
How is the Drug Delivery Systems Market size predicted to change over the forecast window of 2026–2035?
The drug delivery systems market has seen robust growth over recent years. It is anticipated to expand from $44.21 billion in 2025 to $47.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. The expansion witnessed in the past can be ascribed to several factors, including a reliance on conventional oral and injectable delivery methods, the limited range of biologics formulations, an increase in hospital and clinical infrastructure, the rising prevalence of chronic diseases, and growing research and development in pharmaceuticals.
The drug delivery systems market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $62.89 billion by 2030, progressing at a compound annual growth rate (CAGR) of 7.2%. This expected growth during the forecast period stems from developments in polymer and lipid-based delivery systems, the expansion of personalized medicine, a greater reliance on inhalation and transmucosal delivery methods, the growing acceptance of homecare and self-administration devices, and the incorporation of digital monitoring and intelligent delivery technologies. Prominent trends for the forecast period encompass the increasing adoption of targeted and controlled drug release technologies, a surge in the development of biologics and advanced therapeutics, an increase in homecare drug delivery solutions, the broadening use of minimally invasive and needle-free delivery systems, and a heightened focus on ensuring patient compliance and safety.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp
Which Drivers Are Contributing To The Expansion Of The Drug Delivery Systems Market?
The drug delivery systems market is projected to expand in the future, driven by the growing incidence of respiratory ailments. These disorders are conditions that hinder the regular operation of the lungs and airways, resulting in impaired breathing and lower oxygen absorption. The increase in respiratory disorders stems from escalating air pollution, which consistently exposes individuals to harmful airborne substances and gases that damage lung function and exacerbate these conditions. Drug delivery systems play a crucial role in the effective treatment and management of various respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These mechanisms ensure the direct administration of medications to the lungs, thereby improving therapeutic results and reducing systemic adverse effects. For example, the UK Health Security Agency, a UK-based government body, reported in March 2025 that tuberculosis cases in England saw a 13% increase in 2024, reaching 5,480 cases from 4,850 cases in 2023. Consequently, the rising occurrence of respiratory illnesses will significantly propel the drug delivery systems market’s expansion.
What Segment Classifications Make Up The Drug Delivery Systems Market?
The drug delivery systems market covered in this report is segmented –
1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System
2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems
3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications
4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories
Subsegments:
1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors
2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations
3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays
4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery
Which Innovation Trends Are Advancing Developments Within The Drug Delivery Systems Market?
Companies operating within the drug delivery systems market are prioritizing the creation of sophisticated solutions, such as metal-free, multidose nasal spray pumps, aimed at enhancing user comfort and simplifying handling. These metal-free, multidose nasal spray pumps are devices specifically designed to administer multiple medication doses via the nasal passage without incorporating any metal components, thereby guaranteeing safety and compatibility across diverse formulations. For instance, in January 2023, Aptar Pharma, a US-based pharmaceutical company, unveiled its APF Futurity metal-free, multidose nasal spray pump. This particular nasal spray pump is designed for dispensing nasal saline and various other over-the-counter products, with a significant emphasis on its recyclability. It stands as the inaugural highly recyclable nasal spray pump from Aptar Pharma, having achieved a Class AA certification from cyclos-HTP for European recycling systems. Composed entirely of polyolefin materials and devoid of metal parts or recycling contaminants, it contributes to streamlined recycling processes and improves the quality of recyclate. Leveraging Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump guarantees accurate and consistent dosing with gentle operation, all without compromising ease of use or overall effectiveness.
Which Key Market Players Are Investing In Expansion And Innovation Within The Drug Delivery Systems Market?
Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Tandem Diabetes Care, Pacira Biosciences Inc., Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., West Pharmaceutical Services Inc., Catalent Inc., Recipharm AB
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report
Which Region Is Expected To Experience The Fastest Growth In The Drug Delivery Systems Market?
North America was the largest region in the drug delivery system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Drug Delivery Systems Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp
Browse Through More Reports Similar to the Global Drug Delivery Systems Market 2026, By The Business Research Company
Advanced Drug Delivery Systems Global Market Report 2026
Electronic Drug Delivery Systems Global Market Report 2026
Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
